TSVT - 2seventy bio, Inc.

QQQ $ 633.70 $ 0.00 (0 %)

DIA $ 475.18 $ 0.00 (0 %)

SPY $ 684.72 $ 0.00 (0 %)

TLT $ 90.28 $ 0.00 (0 %)

GLD $ 368.88 $ 0.00 (0 %)

Previous Close

$ 5

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 2.29 - $ 5.30

Volume

1,158,184

Average Volume

Market Cap

266.15M

Beta (5Y Monthly)

$ 1.48

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2025	03-31-2025	10-Q
2	03-25-2025	12-31-2024	10-K
3	11-12-2024	09-30-2024	10-Q
4	08-08-2024	06-30-2024	10-Q
5	05-09-2024	03-31-2024	10-Q
6	03-07-2024	12-31-2023	10-K
7	11-14-2023	09-30-2023	10-Q
8	08-14-2023	06-30-2023	10-Q
9	05-10-2023	03-31-2023	10-Q
10	03-16-2023	12-31-2022	10-K
11	11-07-2022	09-30-2022	10-Q
12	08-10-2022	06-30-2022	10-Q
13	05-12-2022	03-31-2022	10-Q
14	03-22-2022	12-31-2021	10-K
15	12-01-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

2seventy bio: Acquisition By Bristol Myers...
05/07/2025 20:16:57

Merger Agreement Details and Path to CompletionFollowing the successful closing of the tender offer, BMS will acquire all remai...

2seventy bio Q1 EPS $0.01 Beats $(0.12) Es...
05/07/2025 20:14:09

2seventy bio (NASDAQ:TSVT) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.12) ...

2seventy Bio Announces Bristol Myers Squib...
05/07/2025 20:08:38

2seventy bio Q4 2024 GAAP EPS $(0.37) Miss...
03/25/2025 20:11:49

2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.24...

Morgan Stanley Maintains Equal-Weight on 2...
03/14/2025 12:19:17

Morgan Stanley analyst Matthew Harrison maintains 2seventy bio (NASDAQ:TSVT) with a Equal-Weight and lowers the price target...

Crude Oil Gains 1%; Ciena Earnings Top Views
03/11/2025 16:02:53

bristol-myers-squibb-scoops-up-its-blood-cancer-drug-partner-2seventy-bio-in-286-million-deal

Bristol Myers Squibb Scoops Up Its Blood C...
03/11/2025 14:17:35

Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last cl...

us-stocks-mixed-kohls-shares-plunge-after-q4-results

US Stocks Mixed; Kohl's Shares Plunge Afte...
03/11/2025 13:56:15

this-lennar-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This Lennar Analyst Is No Longer Bullish; ...
03/11/2025 13:14:54

top-3-health-care-stocks-that-may-keep-you-up-at-night-in-q1

Top 3 Health Care Stocks That May Keep You...
03/11/2025 12:55:38

Leerink Partners Downgrades 2seventy bio t...
03/11/2025 12:20:30

Leerink Partners analyst Daina Graybosch downgrades 2seventy bio (NASDAQ:TSVT) from Outperform to Market Perform and lowers ...

why-paymentus-holdings-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket

Why Paymentus Holdings Shares Are Trading ...
03/11/2025 10:55:36

us-stocks-likely-to-open-higher-after-mondays-selloff-tsla-stock-rebounds-from-its-worst-fall-in-5-years-after-trump-backs-musk-analyst-says-pullbacks-are-normal

US Stocks Likely To Open Higher After Mond...
03/11/2025 10:52:59

U.S. stock futures rose on Tuesday following Monday's heavy selloff. Futures of all four benchmark indices surged in premar...

Reported Earlier, 2seventy bio Agrees To B...
03/11/2025 05:41:10

Transaction Details and Path to CompletionUnder the terms of the agreement, BMS will promptly commence a tender offer to acquir...

novo-nordisk-eyes-2025-regulatory-filing-for-hemophilia-candidate-after-encouraging-pediatric-study-data

Novo Nordisk Eyes 2025 Regulatory Filing F...
02/07/2025 12:50:07

Novo Nordisk's phase 3 trial of Mim8 in children with hemophilia A showed a 0.53 mean annualized bleeding rate, with 74.3% ...

2Seventy Bio Reports Preliminary Full-year...
02/06/2025 12:13:48

2seventy bio Q3 2024 GAAP EPS $(0.19) Beat...
11/12/2024 12:02:00

2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) ...

Earnings Scheduled For November 12, 2024
11/12/2024 08:32:46

2seventy bio Earnings Preview
11/11/2024 14:02:23

europe-drug-regulators-advising-panel-recommends-approval-of-novo-nordisks-australia-approved-hemophilia-drug

Europe Drug Regulator's Advising Panel Rec...
10/18/2024 17:21:46

Novo Nordisk's Alhemo (concizumab) receives a positive opinion from the EMA's CHMP for hemophilia A or B with inhibitor...